# Oral and Sublingual Ketamine

> **NCT07683988** · PHASE1 · NOT_YET_RECRUITING · sponsor: **Western University, Canada** · enrollment: 10 (estimated)

## Conditions studied

- Major Depression Severe

## Interventions

- **DRUG:** 75 mg of oral ketamine
- **DRUG:** Sublingual ketamine 75 mg

## Key facts

- **NCT ID:** NCT07683988
- **Lead sponsor:** Western University, Canada
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-10-01
- **Primary completion:** 2027-08-01
- **Final completion:** 2027-10-01
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2026-07-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07683988

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07683988, "Oral and Sublingual Ketamine". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07683988. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*